Capital Asset Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Capital Asset Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6M	Sell	44,014 -15,461	-26%	-$901K	0.1%	108
2025 Q4	$3.24M	Buy	59,475 +2,110	+4%	+$102K	0.13%	93
2025 Q3	$2.59M	Buy	57,365 +10,291	+22%	+$481K	0.11%	103
2025 Q2	$2.24M	Buy	47,074 +1,069	+2%	+$52.5K	0.1%	104
2025 Q1	$2.74M	Sell	46,005 -2,293	-5%	-$134K	0.14%	96
2024 Q4	$2.73M	Buy	48,298 +83	+0.2%	+$4.64K	0.13%	100
2024 Q3	$2.53M	Buy	48,215 +190	+0.4%	+$8.91K	0.13%	101
2024 Q2	$1.96M	Buy	48,025 +9,216	+24%	+$412K	0.11%	108
2024 Q1	$1.99M	Buy	38,809 +5,010	+15%	+$255K	0.11%	105
2023 Q4	$1.73M	Buy	33,799 +5,454	+19%	+$286K	0.11%	111
2023 Q3	$1.61M	Buy	28,345 +1,418	+5%	+$86.9K	0.11%	100
2023 Q2	$1.67M	Buy	26,927 +1,113	+4%	+$74.6K	0.12%	95
2023 Q1	$1.79M	Buy	25,814 +495	+2%	+$34.9K	0.13%	86
2022 Q4	$1.84M	Buy	25,319 +3,512	+16%	+$265K	0.15%	79
2022 Q3	$1.55M	Sell	21,807 -2,262	-9%	-$164K	0.2%	60
2022 Q2	$1.87M	Buy	24,069 +3,938	+20%	+$300K	0.21%	66
2022 Q1	$1.48M	Buy	20,131 +1,212	+6%	+$81.4K	0.16%	84
2021 Q4	$1.18M	Sell	18,919 -1,020	-5%	-$59.8K	0.13%	119
2021 Q3	$1.19M	Buy	19,939 +1,387	+7%	+$91.3K	0.13%	111
2021 Q2	$1.24M	Sell	18,552 -4,290	-19%	-$280K	0.14%	104
2021 Q1	$1.45M	Buy	22,842 +75	+0.3%	+$4.67K	0.22%	81
2020 Q4	$1.42M	Buy	22,767 +1,987	+10%	+$122K	0.25%	69
2020 Q3	$1.25M	Sell	20,780 -737	-3%	-$44.4K	0.26%	68
2020 Q2	$1.36M	Buy	21,517 +2,542	+13%	+$152K	0.29%	64
2020 Q1	$1.2M	Sell	18,975 -2,088	-10%	-$128K	0.32%	58
2019 Q4	$1.41M	Buy	21,063 +5,161	+32%	+$296K	0.33%	58
2019 Q3	$806K	Buy	15,902 +1,155	+8%	+$54.3K	0.54%	35
2019 Q2	$669K	Buy	+14,747	New	+$687K	0.52%	34
2019 Q1	–	Sell	-10,829	Closed	-$563K	–	77
2018 Q4	$563K	Sell	10,829 -276	-2%	-$14.8K	0.54%	41
2018 Q3	$689K	Sell	11,105 -606	-5%	-$36K	0.58%	40
2018 Q2	$648K	Sell	11,711 -1,826	-13%	-$98.6K	0.58%	41
2018 Q1	$856K	Sell	13,537 -1,318	-9%	-$84.8K	0.79%	32
2017 Q4	$910K	Sell	14,855 -885	-6%	-$55.4K	0.83%	28
2017 Q3	$1M	Buy	15,740 +5,219	+50%	+$305K	0.91%	25
2017 Q2	$587K	Sell	10,521 -710	-6%	-$38.6K	0.38%	64
2017 Q1	$611K	Buy	11,231 +5,718	+104%	+$314K	0.44%	50
2016 Q4	$322K	Buy	5,513 +150	+3%	+$8.2K	0.27%	66
2016 Q3	$289K	Buy	5,363 +310	+6%	+$19.9K	0.38%	47
2016 Q2	$372K	Hold	5,053	–	–	0.49%	37
2016 Q1	$323K	Sell	5,053 -120	-2%	-$7.57K	0.35%	54
2015 Q4	$356K	Buy	+5,173	New	+$342K	0.5%	36

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Asset Advisory Services's BMY Position: Q1 2026 in Review

Capital Asset Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, selling an estimated $901K and leaving 44,014 shares worth $2.6M. The position accounts for 0.1% of the portfolio, ranked #108.

Capital Asset Advisory Services first reported a position in BMY in Q4 2015 and has held it in 41 quarters since. The position peaked at $3.24M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capital Asset Advisory Services held 44,014 shares of Bristol-Myers Squibb worth $2.6M as of Q1 2026.
Capital Asset Advisory Services sold 15,461 Bristol-Myers Squibb shares in Q1 2026, an estimated $901K.
Bristol-Myers Squibb made up 0.1% of Capital Asset Advisory Services's portfolio in Q1 2026, its #108 holding.
Capital Asset Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 41 quarters since.
Capital Asset Advisory Services's Bristol-Myers Squibb position peaked at $3.24M in Q4 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capital Asset Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.